Brief: Shilpa Medicare Says USFDA Concludes Inspection Of Co's Unit VI In Bengaluru
31/10/2024 06:26
Oct 31 (Reuters) - Shilpa Medicare Ltd SHME.NS :
* CONCLUSION OF USFDA INSPECTION OF CO'S UNIT VI IN
BENGALURU
* INSPECTION CONCLUDED WITH ISSUANCE OF FORM 483 WITH FOUR
OBSERVATIONS
Source text: ID:nBSE2Nl2Pb
Further company coverage: SHME.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026